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Background:  Blood glucose level continuously fluctuates within a certain range in the human body. In diabetes patients, the ex-
tent of such fluctuation is large, despite the strict control of blood glucose. Blood glucose fluctuation has been shown to mediate 
more adverse effects on vascular endothelial cells and diabetes complications than chronic hyperglycemia, which has been ex-
plained as due to oxidative stress. As few previous studies have reported the effects of chronic and intermittent hyperglycemia on 
the apoptosis and function of pancreatic beta cells, this study reported herein was performed to investigate such effects on these 
cells.
Methods:  For chronic hyperglycemia, INS-1 cells were cultured for 5 days with changes of RPMI 1640 medium containing 33 mM 
glucose every 12 hours. For intermittent hyperglycemia, the medium containing 11 mM glucose was exchanged with the medium 
containing 33 mM glucose every 12 hours. Apoptosis was assessed by TUNEL assay Hoechst staining and cleaved caspase 3. Insu-
lin secretory capacity was assessed, and the expression of Mn-SOD and Bcl-2 was measured by Western blotting.
Results:  In comparison to the control group, INS-1 cells exposed to chronic hyperglycemia and intermittent hyperglycemia showed 
an increase in apoptosis. The apoptosis of INS-1 cells exposed to intermittent hyperglycemia increased significantly more than the 
apoptosis of INS-1 cells exposed to chronic hyperglycemia. In comparison to the control group, the insulin secretory capacity in 
the two hyperglycemic states was decreased, and more with intermittent hyperglycemia than with chronic hyperglycemia. The ex-
pression of Mn-SOD and Bcl-2 increased more with chronic hyperglycemia than with intermittent hyperglycemia.
Conclusion:  Intermittent hyperglycemia induced a higher degree of apoptosis and decreased the insulin secretory capacity more 
in pancreatic beta cells than chronic hyperglycemia. This activity may be mediated by the anti-oxidative enzyme Mn-SOD and the 
anti-apoptotic signal Bcl-2.
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INTRODUCTION
Hyperglycemia is closely related to the development of macro- 
and microvascular complications of diabetes, and can be pre-
vented by the strict control of blood glucose, as has been prov-
en from large-scale studies, such as the Diabetes Control and 
Complication Trial (DCCT) or the United Kingdom Prospec-
tive Diabetes Study (UKPDS). In such epidemiological stud-
ies, hemoglobin A1C (HbA1c) has been used as the standard 
of glucose control, because it is considered to be relatively ob-
jective and standardized [1,2]. However, in several studies, it 
has been reported that diabetes complications increased more 
in proportion to post-meal glucose or the peak glucose levels, 
rather than the average blood glucose, and these facts were 
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more evident in cardiovascular diseases that account for the 
largest proportion of mortality in diabetes patients [3-7]. 
Therefore, there is a new emphasis on efforts to control all 
three aspects of blood glucose (HbA1c, fasting blood glucose, 
and post-meal blood glucose), as well as to reduce glucose ex-
cursion.
  Even in normal individuals, blood glucose levels fluctuate 
continuously within a certain range. The extent of fluctuation 
is larger in diabetes patients, and there is a large gap between the 
pre-meal and post-meal blood glucose levels. The DCCT study 
group reported that the development of microvascular compli-
cations differed markedly according to the level of HbA1c, as 
well as the extent of blood glucose excursion [8], and similar 
results were reported in prospective studies published thereaf-
ter [9,10]. In in vitro studies, it has been shown that intermittent 
hyperglycemia has a more adverse effect on the survival and 
physiological markers of vascular endothelial cells, as compared 
with chronic hyperglycemia [11,12]. In another study, it was 
reported that the amount of reactive oxygen species (ROS) is 
higher in the intermittent hyperglycemic condition, as com-
pared with that in the chronic hyperglycemic condition [13,14]. 
In a study performed in diabetes patients, free radial production 
was not associated with HbA1c levels or average blood glucose, 
but rather, with glucose fluctuation assessed by the mean am-
plitude of glycemic excursion (MAGE) [13].
  Hyperglycemia induces the apoptosis of pancreatic beta cells 
[15], and a recent study reported that the beta cell function in 
the post-meal condition is closely related to markers reflecting 
the extent of blood glucose fluctuation [16]. Therefore, this ex-
periment was performed to examine the effect of blood glucose 
fluctuation on pancreatic beta cell function under the condi-
tions of chronic and intermittent hyperglycemia.
METHODS
Cell culture
INS-1 cells (Rat insulinoma cell line, passages 30-40) were cul-
tured in RPMI 1640 medium containing 11 mM glucose, 10 
mM HEPES, pH 7.4, 50 μM 2-mercaptoethanol, and 10% fetal 
calf serum, at 37°C, under 95% air and 5% CO2.
Hyperglycemic stress environment
For chronic hyperglycemic status, RPMI 1640 medium con-
taining 33 mM glucose was changed every 12 hours for 5 days 
of culture. For the intermittent hyperglycemic condition, the 
media containing either 11 mM glucose or 33 mM glucose was 
changed alternatively every 12 hours.
Western blotting
After 5 days of hyperglycemic stress, INS-1 cells were washed 
once with PBS, and protein was extracted using lysis buffer 
(Sigma, St. Louis, MO, USA) containing protease inhibitor 
(Roche, Indianapolis, IN, USA). The supernatant was obtained 
by centrifugation at 4°C, 12,000 rpm, for 10 minutes. Protein 
was quantitated by the BCA kit (Pierce, Rockford, IL, USA) 
and Western blotting was performed with a 10% or 12% poly-
SDS page gel and 30 μg of protein per well. Equal protein load-
ing was confirmed by measuring actin expression. The gel was 
transferred to the PVDF membrane, blocked with 5% Skim 
milk/0.1% TTBS (Tris-base 2.42 g, NaCl 8 g, Tween 20 1 mL), 
and reacted with the primary antibodies (1 : 1000) for Mn-SOD 
(Upstate, Billerica, MA, USA), Bcl-2, caspase 3, cleaved caspase 
3, and beta-actin (Cell Signaling, Beverly, MA, USA) at 4°C 
overnight. The secondary antibodies, rabbit and mouse poly-
clonal antibodies (Alkaline-phsophatase conjugated, 1 : 3000) 
(Bio-Rad, Hercules, CA, USA), were reacted at room tempera-
ture for 1 hour stained using the a AP-conjugated substrate kit 
(Bio-Rad).
Terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL)
After culturing on coverslides, INS-1 cells were incubated un-
der hyperglycemic condition for 5 days and washed with PBS. 
Then, we added 100 μL fixation/permeabilization solution (BD 
Bioscience, San Jose, CA, USA) to the slides, incubated them 
at room temperature for 20 minutes, and then washed them 
with PBS. Subsequently, 50 μL TUNEL mixture (Roche) was 
added, with the light blocked, and reacted at 37°C for 1 hour. 
The cells were then analyzed by fluorescent in situ hybridiza-
tion (FISH).
Hoechst 33347 staining
After culturing on coverslides, INS-1 cells were incubated un-
der a hyperglycemic condition for 5 days and washed with PBS. 
We then added 100 μL fixation/ permeabilization solution to 
the slides, incubated the slides at room temperature for 20 min-
utes, and then washed them with PBS. Subsequently, 100 μL 
Hoechst 33342 (Sigma) (1 μg/mL) was added, with the light 
blocked, and reacted at 3°C for 30 minutes. The cells were then 
analyzed by FISH.49
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Measurement of insulin secretory capacity
To examine the level of insulin secretion in response to hyper-
glycemia, the supernatant was removed, and the cells were 
starved in medium containing 5 mM glucose and 2% fetal calf 
serum for 5 hours and then incubated with the Krebs-Ringer 
buffer (119 mM NaCl, 4.75 mM KCl, 2.54 mM CaCl2, 1.2 mM 
MgSO4, 1.2 mM KH2PO4, 5 mM NaHCO3, 20 mM HEPES, pH 
7.4) containing either 5 mM or 25 mM glucose for 1 hour. The 
culture medium was added to the Rat/Mouse Insulin ELISA 
kit (LINCO Research, St. Louis, MO, USA). The color change 
was observed, and the optical density at 450 nm was mea-
sured.
Statistical analysis
Experimental results were statistically analyzed using the SPSS 
version 15.0 (SPSS Inc., Chicago, IL, USA). All values are pre-
sented as the mean ± standard deviation, and analyzed with the 
Student’s t-test and ANOVA test. A P < 0.05 was considered to 
be statistically significant.
RESULTS
The effect of chronic and intermittent hyperglycemia on 
the apoptosis of INS-1 cells
In both chronic and intermittent glycemic conditions, the 
amount of the cleaved caspase 3 increased by approximately 
30% and 47%, respectively, as compared with the control group. 
In the intermettent hyperglycemic condition, the expression 
of caspase 3 was lower, and the amount of the cleaved caspase 
3 was higher, as compared with the chronic hyperglycemic con-
dition (Fig. 1). Upon Hoechst staining, more DNA fragmenta-
tion was observed in both hyperglycemic conditions, as com-
pared with the control group, and positive staining was signifi-
cantly higher with intermittent hyperglycemia than with chron-
ic hyperglycemia (Fig. 2). In the TUNEL assay, the percentage 
of positively stained cells was 10% in the control group, 40% in 
the intermittent hyperglycemic group, and 20% in the chronic 
hyperglycemic group. Apoptosis was significantly higher with 
intermittent hyperglycemia than with chromic hyperglycemia 
(Fig. 3).
Fig. 1.  Expression of caspase 3 and cleaved caspase 3 in INS-1 cell. (A) Caspase 3 and cleaved caspase 3 were measured by West-
ern blot analysis. (B, C) Densitometric analyses of Western blot are reported as means ± SD of the three different experiments. C, 
control; IHG, intermittent high glucose; SHG, sustained high glucose. 
aP < 0.05 vs. control, 
bP < 0.05 vs. IHG.
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Insulin secretory capacity in chronic and intermittent 
hyperglycemic condition
At the 5-mM glucose level, the amount of insulin secretion was 
not significantly different between the control and hyperglyce-
mia groups. However, when stimulated with 25 mM glucose, 
the amount of insulin secretion was decreased by 60% and 43% 
in both the chronic and intermittent hyperglycemia groups, re-
spectively, and was significantly lower in the intermittent hy-
perglycemia group, as compared with the chronic hyperglyce-
mia group (Fig. 4).
Difference in the expression of Mn-SOD and bcl-2
The expression of Mn-SOD, an anti-oxidative enzyme, was 
higher under chronic hyperglycemic conditions and under in-
termittent hyperglycemic conditions by 64% and 29%, respec-
tively, as compared with the control group, in which no oxida-
tive stress was present. The expression of MnSOD was signifi-
cantly higher in the intermittent hyperglycemic group than in 
the chronic hyperglycemic group. In comparison with the con-
trol group, both the chronic and intermittent hyperglycemic 
groups showed a decrease in the expression of Bcl-2, an anti-
apototic signal. The level of Bcl-2 expression was significantly 
higher in the chronic hyperglycemic group than in the inter-
mittent hyperglycemic group (Fig. 5).
DISCUSSION
The effect of blood glucose fluctuation on diabetes complica-
tions or beta cell function has not been established. Although 
the influence of glucose control, as assessed primarily by HbA1c 
levels, on the development of diabetes complications has been 
proven in numerous large-scale epidemiological studies, there 
Fig. 2.  Hoechst 33347 staining. (A) After INS-1 cell were incubated under control, IHG and SHG, they were stained with 
Hoechst 33347 to detect apoptosis morphologically. The red arrows represent cells with DNA condensation. (B) The numbers of 
cells with broken DNA per 300 cells in three different fields in each condition of one experiment were counted and repeated in 
three different experiments. The mean percentages of positive staining under control, IHG and SHG were presented by histo-
gram. C, control; IHG, intermittent high glucose; SHG, sustained high glucose. 
aP < 0.05 vs. control, 
bP < 0.05 vs. IHG.
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are few well-designed studies that demonstrate a direct effect 
of post-meal hyperglycemia or blood glucose fluctuations on 
diabetes complications. However, similar results have been ob-
served in retrospective analyses from the DCCT study, which 
reported that HbA1c, as well as blood glucose fluctuation, seem 
to be associated with the microvascular complications of dia-
betes [8]. In a study performed on vascular endothelial cells 
associated with diabetes cardiovascular complications, it was 
reported that vascular endothelial cell function deteriorated 
more with oscillating glucose concentrations [12]. Nonethe-
less, few studies have reported on the effect of blood glucose 
fluctuations on beta cell function or survival, which is impor-
tant in the pathophysiology of diabetes.
  One of the reasons for the deleterious effects of glucose fluc-
tuations on vascular complications is the relatively increased 
oxidative stress associated with hyperglycemic status, as com-
pared with normoglycemic status. In a study performed in non-
Fig. 3.  Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL). (A) TUNEL stainings under control, IHG and 
SHG were analyzed by fluorescent in situ hybridization (FISH). (B) The percentage of TUNEL positive apoptotic cells / area was 
presented in histogram. C, control; IHG, intermittent high glucose; SHG, sustained high glucose. 
aP < 0.05 vs. control, 
bP < 0.05 
vs. IHG.
Fig. 4.  Insulin secretion from INS-1 cells in response to glu-
cose (5 and 25 mM) after incubated for 5 days in control, IHG 
and SHG. Data are means ± SD of three separate experiments. 
C, control; IHG, intermittent high glucose; SHG, sustained 
high glucose. 
aP < 0.05 vs. control of 25 mM glucose, 
bP < 0.05 
vs. IHG of 25 mM glucose.
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obese non-diabetic subjects, when blood glucose fluctuations 
were induced by a hyperglycemic clamp, the activity of prosta-
cyclin synthase, an endothelial cell enzyme known to suppress 
atherosclerosis, was noticeably decreased, suggesting an adverse 
effect from the free radicals generated in response to blood 
glucose fluctuations on vascular endothelial cells [8]. It is well 
known that hyperglycemia increases oxidative stress in diabe-
tes patients, and, compared with non-diabetic individuals, free 
radical production has been reported to be nearly 2-fold high-
er in diabetes patients [17]. In another study performed in dia-
betes patients, it was reported that the concentration of 8-iso 
PGF2a was 4-fold higher in the group with the largest blood 
glucose fluctuations, as compared with the group with the low-
est blood glucose fluctuations [13]. In a study measuring the 
level of oxidative stress in diabetes patients, although the level 
of oxidative stress showed no significant association with the 
average 24-hour urine glucose, fasting glucose level or HbA1c 
level, was significantly correlated with the markers of glucose 
fluctuation, suggesting that oxidative stress increases more 
when the extent of glucose fluctuation is substantial [13].
  Few studies have reported on the effect of oxidative stress 
within beta cells in the intermittent hyperglycemic state, on 
subsequent beta cell apoptosis and alteration of other intracel-
lular signaling. In a study in which islet and INS-1 cells were ex-
posed to 11 mM and 25 mM glucose alternately for 72 hours, 
the concentration of 8-OhdG increased substantially more with 
intermittent hyperglycemia than with chronic hyperglycemia 
[14]. Similar to results from our study, both the islet and INS-1 
cells showed a greater reduction in expression of insulin mRNA, 
insulin content, and GSIS with intermittent hyperglycemia than 
with chronic hyperglycemia. Although the fact that hypergly-
cemia induces an increase in the apoptosis of islet cells has been 
confirmed [15], there have been few studies comparing the ef-
fects of intermittent and chronic hyperglycemia on beta cell 
apoptosis. In a previous study, when cell viability was exam-
ined by MTT assay, more decreased cell viability was shown 
with intermittent hyperglycemic than with chronic hypergly-
cemia, although the difference was not statistically significant 
Fig. 5.  The changes of the expression of MnSOD and Bcl-2 in response to control, IHG and SHG. (A) Expression of Mn-SOD 
and Bcl-2 were evaluated by Western blot analysis. A representative experiment of three is shown. (B, C) Densitometric analyses 
of western blot are reported as means ± SD of the three different experiments. C, control; IHG, intermittent high glucose; SHG, 
sustained high glucose. 
aP < 0.05 vs. control, 
bP < 0.05 vs. IHG.
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[14]. The strength of our study is that we used three different 
assays (TUNEL, Hoechst, and cleaved caspase 3) to confirm 
the increase in apoptosis in INS-1 cells under intermittent hy-
perglycemic conditions, as compared to chronic hyperglyce-
mic conditions.
  It is difficult to adequately explain why intermittent hyperg-
lycemia is more deleterious to the cell with more increased ox-
idative stress than that with chronic hyperglycemic status. One 
possible explanation is that, when cells are continuously ex-
posed to hyperglycemia, certain compensation or feedback re-
actions are induced to compensate for the stimulation. How-
ever, in the intermittent hyperglycemic state, it is speculated 
that such an adaptative reaction is reduced or does not function 
very well [11]. As one of such compensatory reactions, levels 
of ER stress markers in chronic hyperglycemia were reported 
to be lower than those in intermittent hyperglycemia [14]. The 
expression of anti-oxidative enzymes in pancreatic beta cells is 
known to be lower than in other cells in our body; hence, pan-
creatic beta cells are more vulnerable to oxidative stress [18]. 
In a recent study, it is reported that the Bcl-2 family is required 
for apoptosis in pancreatic beta cells, and mutations in this an-
ti-apoptosis signal cause increased sensitivity to various stim-
ulations, allowing apoptosis to readily occur in response to a 
weak stimulation [19]. In addition, regulation of the expression 
of the Bcl-2 family can reverse cell injury caused by oxidative 
stress [20]. In our study, the expression of the anti-oxidant en-
zyme Mn-SOD and the expression of the anti-apoptosis signal 
Bcl-2 increased more with chronic hyperglycemia than with 
intermittent hyperglycemia. These results could be a partial ex-
planation for decrease in beta cell apoptosis with chronic hy-
perglycemia, as compared with intermittent hyperglycemia.
  There are some limitations to our study. First, we did not di-
rectly measure the concentration of ROS or oxidants, nor did 
we compare their levels under chronic and intermittent hyper-
glycemic status. However, such results have been reported in 
previous studies, and our study was conducted based on those 
study results. Secondly, our study results were not performed 
in vivo or in primary islet culture experiments. Therefore, to ap-
ply our study results in clinical practice, more extensive studies 
are necessary.
  In conclusion, we observed that, even under identical degrees 
of hyperglycemia, the apoptosis of INS-1 cells is higher, and 
GSIS is lower, with intermittent hyperglycemic conditions, as 
compared with chronic hyperglycemic conditions. Higher ex-
pression of Mn-SOD and Bcl-2 in chronic hyperglycemia, as 
compared with intermittent hyperglycemia, could be a partial 
explanation for the mechanism underlying our observations.
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